RecruitingNCT07325279
Safety and drug levels of nalmefene implants in healthy adults
About this title
Read the official source — NCT07325279Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
This study is for healthy volunteers. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- MorrisvilleSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 23, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 24
- Sponsor
- ReacX Pharmaceuticals, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07325279
- Official title
Show the full official title
A Phase 1, Open-Label, Safety, Tolerability, and Pharmacokinetic Study of Nalmefene Implants in Healthy Subjects
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Morrisville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is ReacX Pharmaceuticals, Inc.
Does this study involve medication?
Yes. The study involves medication, including 1 Nalmefene implant and 2 Nalmefene implants.
Who can participate?
This study is for healthy volunteers. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
